stock rebound

Nebius Group NBIS Stock After Hours Dec 18 2025: Why Shares Rebounded, Latest News, Analyst Targets, and What to Watch Before Friday’s Open

Nebius Group N.V. (Nasdaq: NBIS) finished Thursday, December 18, 2025 with a sharp rebound, and the stock remained active in extended trading as investors digested fresh AI-infrastructure headlines, renewed debate about “neocloud” debt funding, and a macro backdrop that turned

19 December 2025

Global Stock Markets Today (18 December 2025, 1:55): Stocks Rebound on Softer US Inflation as BoE Cuts and ECB Holds; AI Trade Still Volatile

Global stock markets swung through a familiar late‑2025 pattern on Thursday: early caution led by tech and “AI bubble” nerves, followed by a broad rebound as softer‑than‑expected U.S. inflation revived rate‑cut hopes and Europe’s central banks delivered mostly in line

18 December 2025

AI Trading · Central Banks · Global Markets · Inflation · Market Volatility

GE Vernova Stock (NYSE: GEV) Rebounds on Dec. 18, 2025 as Jefferies Upgrades; Analysts Lift Targets After AI-Driven Selloff

December 18, 2025 — GE Vernova Inc. (NYSE: GEV) is back in focus today after a sharp, headline-driven swing that reminded investors just how tightly the stock has become linked to the “AI power demand” trade. After a steep drop

18 December 2025

AI Trends · Analyst Upgrades · Energy · Investment · NYSE:GEV · Stock Market

Meta Platforms (META) Jumps as Google AI Chip Talks, Analyst Upgrade and Legal Shift Fuel 26 November 2025 Rebound

November 26, 2025 – US markets mid‑session update Meta Platforms, Inc. (NASDAQ: META) is back in rally mode today. By early afternoon UTC, Meta stock was trading around $636 per share, up roughly 3.8% on the session, giving the social

26 November 2025

AI News · Legal Updates · Market Trends · Social Media · Stock Analysis

Sarepta Therapeutics (SRPT) Surges After FDA Greenlights Duchenne Gene Therapy – Is a Rebound Ahead?

Stock Performance and Trends Sarepta’s stock is recovering some ground after steep losses. As of Oct 2, 2025, SRPT closed at $19.57, up about 6.8%for the day investing.com. This followed a general uptrend in recent weeks: SRPT is up roughly 16% over the last

2 October 2025

Biotech · FDA Approvals · Gene Therapy · NASDAQ:SRPT · Pharmaceuticals · Stock Analysis · Stock Market